ANDRIGHETTO, ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 3.458
AS - Asia 1.847
EU - Europa 1.316
AF - Africa 532
SA - Sud America 442
OC - Oceania 57
Continente sconosciuto - Info sul continente non disponibili 28
Totale 7.680
Nazione #
US - Stati Uniti d'America 3.224
SG - Singapore 713
CN - Cina 357
IT - Italia 314
BR - Brasile 287
HK - Hong Kong 229
DE - Germania 154
FI - Finlandia 93
PL - Polonia 74
SE - Svezia 70
VN - Vietnam 62
NL - Olanda 52
RU - Federazione Russa 51
BJ - Benin 49
GB - Regno Unito 47
FR - Francia 42
AT - Austria 35
IN - India 33
CI - Costa d'Avorio 31
AR - Argentina 27
JP - Giappone 27
ZA - Sudafrica 27
IE - Irlanda 26
UZ - Uzbekistan 24
CH - Svizzera 23
ES - Italia 23
EC - Ecuador 22
ID - Indonesia 21
CV - Capo Verde 20
KR - Corea 20
PY - Paraguay 20
UA - Ucraina 20
CA - Canada 19
GA - Gabon 19
LA - Repubblica Popolare Democratica del Laos 19
MX - Messico 19
NZ - Nuova Zelanda 19
DK - Danimarca 18
IQ - Iraq 18
TR - Turchia 18
BA - Bosnia-Erzegovina 17
TJ - Tagikistan 17
UY - Uruguay 17
AM - Armenia 16
BE - Belgio 16
BF - Burkina Faso 16
DO - Repubblica Dominicana 16
KE - Kenya 16
LU - Lussemburgo 16
MA - Marocco 16
PT - Portogallo 16
TZ - Tanzania 16
BD - Bangladesh 15
CZ - Repubblica Ceca 15
NI - Nicaragua 15
PH - Filippine 15
RO - Romania 15
RS - Serbia 15
TN - Tunisia 15
AZ - Azerbaigian 14
BO - Bolivia 14
CD - Congo 14
CW - ???statistics.table.value.countryCode.CW??? 14
DZ - Algeria 14
GF - Guiana Francese 14
HR - Croazia 14
LY - Libia 14
MN - Mongolia 14
MR - Mauritania 14
MY - Malesia 14
NP - Nepal 14
XK - ???statistics.table.value.countryCode.XK??? 14
ZM - Zambia 14
AO - Angola 13
BB - Barbados 13
CM - Camerun 13
CY - Cipro 13
GT - Guatemala 13
JO - Giordania 13
LV - Lettonia 13
PA - Panama 13
RE - Reunion 13
SA - Arabia Saudita 13
YE - Yemen 13
AL - Albania 12
AU - Australia 12
BY - Bielorussia 12
CL - Cile 12
CO - Colombia 12
CR - Costa Rica 12
CU - Cuba 12
GN - Guinea 12
IL - Israele 12
JM - Giamaica 12
MG - Madagascar 12
NG - Nigeria 12
NO - Norvegia 12
TW - Taiwan 12
VC - Saint Vincent e Grenadine 12
AE - Emirati Arabi Uniti 11
Totale 7.196
Città #
Singapore 455
Fairfield 394
Ashburn 373
Ann Arbor 281
Chandler 232
Houston 226
Hong Kong 220
Woodbridge 199
Beijing 149
Seattle 146
Cambridge 143
Wilmington 112
Boardman 93
Munich 73
Padova 67
Santa Clara 63
Los Angeles 61
Bytom 48
Princeton 47
Cotonou 45
Medford 43
San Diego 41
Turku 36
Helsinki 32
New York 32
Abidjan 31
Des Moines 29
Legnaro 27
Roxbury 26
São Paulo 26
Vienna 25
Buffalo 24
Milan 24
Nuremberg 24
Tashkent 24
Nanjing 21
Dublin 20
L’Aquila 19
Ho Chi Minh City 18
Libreville 18
Warsaw 18
Hanoi 16
Tokyo 16
Vientiane 16
Chicago 15
Dushanbe 15
Managua 15
Nairobi 15
Lusaka 14
Nouakchott 14
Ulan Bator 14
Amman 13
Hefei 13
Montevideo 13
Praia 13
Willemstad 13
Antananarivo 12
Auckland 12
Baku 12
Bridgetown 12
Brooklyn 12
Conakry 12
Dar es Salaam 12
Johannesburg 12
Kingstown 12
Kinshasa 12
Panama City 12
Riga 12
Havana 11
Kigali 11
Luanda 11
Minsk 11
Yerevan 11
Andorra la Vella 10
Cayenne 10
Dakar 10
Kingston 10
Kuala Lumpur 10
Luxembourg 10
Noumea 10
Ouagadougou 10
Phnom Penh 10
Redondo Beach 10
Sanaa 10
Bamako 9
Boston 9
Limassol 9
Maputo 9
Seoul 9
Atlanta 8
Belgrade 8
Belo Horizonte 8
Bishkek 8
Brescia 8
Brussels 8
Castries 8
Djibouti 8
Guatemala City 8
Harare 8
Kampala 8
Totale 4.642
Nome #
Early Evaluation of Copper Radioisotope Production at ISOLPHARM 204
Off-line ionization tests using the surface and the plasma ion sources of the SPES project 202
The RIB production target for the SPES project 179
Studies for aluminum photoionization in hot cavity for the selective production of exotic species project 166
On-line test using multi-foil SiC target at iThemba LABS 166
A New Preclinical Decision Support System Based on PET Radiomics: A Preliminary Study on the Evaluation of an Innovative64Cu-Labeled Chelator in Mouse Models 163
Nanocrystalline titanium carbide/carbon composites as irradiation targets for isotopes production 159
SPES: A new cyclotron-based facility for research and applications with high-intensity beams 158
Future perspectives of the Legnaro National Laboratories: The SPES project 156
Test on the electrostatic dipoles and steerers for the 1+ beam line of the SPES project 156
A combined experimental and numerical approach for the control and monitoring of the SPES target during operation at high temperature 155
The SPES project at LNL: Status of the project, technical challenges, instrumentation, scientific program 155
Graphene derived lanthanum carbide targets for the SPES ISOL facility 154
Radioactive Ion beams at INFN laboratories 153
Photo-ionization of aluminum in a hot cavity for the selective production of exotic species project 150
Use of polymeric fibers to increase gas permeability of lanthanum carbide based targets for nuclear physics applications 149
Neutron irradiation effects on standard and oxygenated silicon diodes 137
The SPES project: An ISOL facility for exotic beams 135
The SPES On-Line Front End Commissioning Test Setup 132
High temperature compression tests on graphite POCO EDM-3, used in devices for SPES project 132
Remote handling of radioactive targets at the SPES facility 130
The SPES High Power ISOL production target 130
A semi-quantitative risk assessment of remote handling operations on the SPES Front-End based on HAZOP-LOPA 130
The SPES Target and Ion Source unit 128
The ISOLPHARM project: A New ISOL production method of high specific activity beta-emitting radionuclides as radiopharmaceutical precursors 126
Laser Ablation Experiments at SPES Laser Laboratory 124
Electrical-thermal-structural finite element simulation and experimental study of a plasma ion source for the production of radioactive ion beams 123
The SPES Project at LNL 123
Chemical purification of 111Ag from isobaric impurity 111Cd by solid phase extraction chromatography: a proof of concept study 123
Sucrose-based sol-gel synthesis of microporous titanium carbide as target material for the production of radioisotopes 122
Thermal-electric coupled-field finite element modeling and experimental testing of high-temperature ion sources for the production of radioactive ion beams 120
Preliminary design of the Target Window for SPES Project at LNL 120
Morphological and functional effects of graphene on the synthesis of uranium carbide for isotopes production targets 118
Effect of sacrificial fiber length on gas permeability of lanthanum carbide 117
Time dependent thermal study for the SPES Target – Ion Source system 117
The SPES target ion source automated storage system 116
Low energy radioactive ion beams at SPES for nuclear physics and medical applications 111
An Innovative Production Method for Therapeutic Carrier-free Radiopharmaceuticals 111
Synthesis of small molecule-based ligands for active targeting of CCK2R for the ISOLPHAR-Ag project 110
First Calculation of Radiation Damage of Front End Components Using FLUKA Code 108
New solid state laser system for SPES: Selective Production of Exotic Species project at Laboratori Nazionali di Legnaro 107
Toward novel sulphur-containing derivatives of tetraazacyclododecane: Synthesis, acid-base properties, spectroscopic characterization, DFT calculations, and cadmium(ii) complex formation in aqueous solution 103
Chromatographic separation of silver-111 from neutron-irradiated palladium target: toward direct labeling of radiotracers 99
Thermal and Mechanical Characterization of Carbides for High Temperature Nuclear Applications 97
Use of polymeric fibers to obtain high permeability lanthanum carbide SPES target prototypes 95
Tuning the Framework of Thioether-Functionalized Polyazamacrocycles: Searching for a Chelator for Theranostic Silver Radioisotopes 93
Development and Validation of Novel Z-360-Based Macromolecules for the Active Targeting of CCK2-R 90
Risk Assessment of the SPES On-Line Front End: HAZOP and LOPA Analysis 90
Maintenance assessment of the SPES Front-End 89
Productionvof carrier-free copper radionuclides with the ISOLPHARM method for nuclear medicine 89
Remote handling systems for the Selective Production of Exotic Species (SPES) facility 87
Cyclotron-based production of innovative medical radionuclides at the INFN-LNL: state of the art and perspective 87
The SPES ISOL-RIB unit 86
Status of the SPES ISOL Front-End: installation and commissioning plan 85
The ISOLPHARM project: ISOL technique for radiopharmaceuticals development 84
Product ion of Carrier Free Copper Nuclides with the ISOL Method for Nuclear Medicine 82
Study of the radionuclide deposition in the radioactive ion line of the Selective Production of Exotic Species (SPES) facility 80
Research and technological development of beta-emitting radiopharmaceuticals produced with radioactive ion beams 74
Spes: An intense source of Neutron-Rich Radioactive Beams at Legnaro 74
Study of the radioactive contamination of the ion source complex in the Selective Production of Exotic Species (SPES) facility 73
The SPES target production and characterization 72
The SPES Temporary Storage System: status and future perspectives 71
The SPES target ion source automated storage system 68
Biodistribution Assessment of a Novel 68Ga-Labeled Radiopharmaceutical in a Cancer Overexpressing CCK2R Mouse Model: Conventional and Radiomics Methods for Analysis 64
Ongoing Developments for the ISOLPHARM Project: new ISOL Target Concepts 61
Monte Carlo dosimetry of silver-111 in simplified cell geometries in the framework of the ISOLPHARM project 27
Resonant Laser Ionization and Fine-Structure Study of Silver in an Ablation Plume 22
The SPES-ISOLPHARM beamline for the production of medical radionuclides at INFN-LNL 19
null 17
Laser photo-ionization efficiency of 111Ag for medical use in the SPES-ISOLPHARM project 16
Laser photo-ionization study of natAg using opto-galvanic signal at SPES offline laser lab 15
Benchmark of a biophysical model for the radiobiology of RNT with 125I-labelled agents 12
Totale 7.796
Categoria #
all - tutte 26.845
article - articoli 23.360
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.205


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021286 0 0 0 0 12 18 11 36 74 48 57 30
2021/2022613 23 99 53 57 13 27 28 71 28 16 61 137
2022/2023523 75 46 26 56 85 66 2 27 69 18 42 11
2023/2024463 28 45 63 26 13 71 49 10 21 42 46 49
2024/20251.679 10 147 63 57 152 54 65 174 158 55 288 456
2025/20262.883 374 503 867 1.067 72 0 0 0 0 0 0 0
Totale 7.796